Triple negative breast carcinoma is a prognostic factor in Taiwanese women

BackgroundCurrently, there is a debate as to whether triple negative breast carcinoma (TNBC) has a worse prognosis than non-TNBC. Our aim was to determine whether TNBC is a prognostic factor for survival.MethodsWe identified 1,048 Taiwanese breast carcinoma patients, of whom 167 (15.9%) had TNBC. Data used for analysis were derived from our cancer registry database for women with breast cancer who were diagnosed between 2002 January and 2006 December.ResultsIn the Kaplan-Meier analysis, tumor subgroup (TNBC vs. non-TNBC) was a prognosis factor related to 5-year overall survival. In the univariate analysis, tumor subgroup (TNBC vs. non-TNBC) was a significant factor related to 5-year overall survival, in addition to age, tumor size, lymph node, metastasis, grade, stage, estrogen receptor status, progesterone receptor status, and HER2 overexpression status. In the multivariate analysis, tumor subgroup was not a significant factor related to 5-year disease-free survival (DFS). In node-positive patients, tumor subgroup was a significant factor related to 5-year overall survival, in addition to age, tumor size, metastasis, and grade. In node-negative patients, tumor subgroup was not a significant factor related to 5-year disease-free survival and 5-year overall survival.ConclusionOur results indicated that TNBC patients in Taiwan have worse 5-year overall survival than non-TNBC patients. Notably, in node-positive patients, TNBC played a prognostic role in 5-year overall survival.

• Publication year

  2009

• Venue

  BMC Cancer

• Publication date

  2009-06-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/1471-2407-9-192PMID 19534825PMCID 2706258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients

  2009influential reference
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2009cited by this paper
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008influential reference
• HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information

  2008cited by this paper
• The prognostic importance of triple negative breast carcinoma.

  2008influential reference
• Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

  2008cited by this paper
• Basal-like breast cancer: a critical review.

  2008cited by this paper
• Is triple negative a prognostic factor in breast cancer?

  2008cited by this paper
• The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

  2008cited by this paper
• Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

  2008cited by this paper
• Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

  2008cited by this paper
• Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

  2008cited by this paper
• The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races.

  2007cited by this paper
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

  2007cited by this paper
• TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

  2007cited by this paper
• Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

  2007influential reference
• Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.

  2007cited by this paper
• Prognostic markers in triple‐negative breast cancer

  2007influential reference
• Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.

  2006influential reference
• The Challenging Estrogen Receptor‐Negative/ Progesterone Receptor‐Negative/HER‐2‐Negative Patient: A Promising Candidate for Epidermal Growth Factor Receptor‐Targeted Therapy?

  2006cited by this paper
• Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer

  2006cited by this paper
• Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

  2006cited by this paper
• Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006influential reference

• Association of progesterone receptor status with breast cancer prognosis: a meta-analysis

  2025influential citation
• Development and evaluation of a predictive model for postoperative recurrence and metastasis in breast cancer using an artificial intelligence ultrasound breast system.

  2025cites this paper
• Survival Analysis of Young Triple-Negative Breast Cancer Patients

  2024cites this paper
• Crosstalk between angiogenesis and immune regulation in the tumor microenvironment

  2022cites this paper
• RUNX Family in Hypoxic Microenvironment and Angiogenesis in Cancers

  2022cites this paper
• Chlamydia Trachomatis Infection: Their potential implication in the Etiology of Cervical Cancer

  2021cites this paper
• Analysis of Salmonella typhimurium Protein-Targeting in the Nucleus of Host Cells and the Implications in Colon Cancer: An in-silico Approach

  2020cites this paper
• The inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.

  2020cites this paper
• Bioinformatics approach to understand the mode of microbial pathogenesis of Chlamydia trachomatis and their implications in gynecologic malignancy.

  2020cites this paper
• Long non-coding RNAs: Functional regulatory players in breast cancer

  2019cites this paper
• Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer

  2019cites this paper
• Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort

  2018cites this paper
• Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma.

  2018cites this paper
• A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression.

  2018cites this paper
• Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.

  2018cites this paper
• Rate of Distant Metastases on 18F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 Years

  2017cites this paper
• Expression profile of urothelial transcription factors in bladder biopsies with interstitial cystitis

  2017cites this paper
• A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression

  2016cites this paper
• High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients

  2016cites this paper
• Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling

  2016cites this paper
• Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology

  2016cites this paper
• ID1对非小细胞肺癌EGFR-TKI耐药的影响

  2016cites this paper
• Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines

  2016cites this paper
• Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity

  2015cites this paper
• Mammographic tumour appearance and triple-negative breast cancer associated with long-term prognosis of breast cancer death: a Swedish Cohort Study.

  2015cites this paper
• Epidemiologic and clinicopathologic evaluation of patients with breast cancer referred to Ghaem Hospital from 2005 to 2014

  2015cites this paper
• Understanding the function and mechanisms of intestinal cell kinase in the growth and survival of prostate cancer cells

  2015cites this paper
• Risk of cancer among HIV-infected patients from a population-based nested case–control study: implications for cancer prevention

  2015cites this paper
• Computational prediction of Escherichia coli proteins host subcellular targeting and their implications in colorectal cancer etiology.

  2015cites this paper
• Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.

  2014cites this paper
• The role of inhibitor of DNA-binding 1 (ID-1) protein and angiogenesis in serous ovarian cancer.

  2014cites this paper
• The latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markers.

  2014cites this paper
• Inhibitor of differentiation 1 is a candidate prognostic marker in multicentric Castleman’s disease

  2014cites this paper
• Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms

  2014cites this paper
• Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.

  2014cites this paper
• Paclitaxel-exposed ovarian cancer cells induce cancer‑specific CD4+ T cells after doxorubicin exposure through regulation of MyD88 expression.

  2014cites this paper
• Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer

  2014cites this paper
• Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways

  2013cites this paper
• Invasive Micropapillary Carcinoma of the Breast: A Clinicopathologic Study of 103 Cases of an Unusual and Highly Aggressive Variant of Breast Carcinoma

  2013cites this paper
• Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.

  2013cites this paper
• Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer

  2013cites this paper
• EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast

  2013cites this paper
• Drosophila T-Box Transcription Factor Midline Functions in the Notch-Delta Signaling Pathway to Regulate Sensory Organ Precursor Cell Fate and Cell Survival and Embryonic Development Profile of Midline, Senseless, and Achaete in the CNS and PNS

  2013cites this paper
• Original Article Expression of Id-1 and VEGF in non-small cell lung cancer

  2013cites this paper
• Serum regulation of Inhibitor of DNA Binding/Differentiation 1 expression by a BMP pathway and BMP Responsive Element

  2013cites this paper
• Expression of Id-1 and VEGF in non-small cell lung cancer.

  2013cites this paper
• Significance of Histomorphology of Early Triple-Negative Breast Cancer

  2012cites this paper
• A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers

  2012cites this paper
• Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review.

  2012cites this paper
• Clinico-Pathological Characteristics of Triple Negative and Non Triple Negative High Grade Breast Carcinomas with and Without Basal Marker (CK5/6 and EGFR) Expression at a Rural Tertiary Hospital in India

  2012cites this paper
• Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B

  2012cites this paper
• A 10-year follow-up of triple-negative breast cancer patients in Taiwan.

  2012cites this paper
• Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan

  2011cites this paper
• Clinicopathological features of triple-negative breast cancer in Taiwanese women

  2011cites this paper
• Id1: a novel therapeutic target for patients with atherosclerotic plaque rupture.

  2011cites this paper
• Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

  2011cites this paper
• Acheron regulates vascular endothelial proliferation and angiogenesis together with Id1 during wound healing

  2011cites this paper
• Triple‐negative breast cancer in Hispanic patients

  2011cites this paper
• Alterations in diet consistency and variation in Hypoxia Inducible Factor-1α expression in condylar chondrocytes.

  2011cites this paper
• Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women.

  2011cites this paper
• Id-2 protein expression and microvessel density assessment in various types of malignant ovarian tumors

  2010cites this paper
• The PI3K/Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells

  2010cites this paper
• The role of Id1 expression with EGF and EGF-R serum concentration assessment in malignant ovarian tumours

  2010influential citation
• Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes

  2010cites this paper
• Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival

  2010cites this paper
• Triple-negative breast cancer: disease entity or title of convenience?

  2010cites this paper
• Ovarian cancer creates a suppressive microenvironment to escape immune elimination.

  2010cites this paper